These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 33017027)

  • 21. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
    Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
    Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
    Jiang F; Wu C; Wang M; Wei K; Wang J
    Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Front Genet; 2020; 11():333. PubMed ID: 32391054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immune-related risk gene signature predicts the prognosis of breast cancer.
    Cao W; Jiang Y; Ji X; Ma L
    Breast Cancer; 2021 May; 28(3):653-663. PubMed ID: 33400208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine.
    Li Z; Liu H; Zhang M; Wang J; Peng Q; Jiang N; Wei Y
    Front Biosci (Landmark Ed); 2024 Jun; 29(7):239. PubMed ID: 39082332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
    Wang X; Tan C; Ye M; Wang X; Weng W; Zhang M; Ni S; Wang L; Huang D; Huang Z; Xu M; Sheng W
    J Cancer; 2020; 11(20):5918-5928. PubMed ID: 32922534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
    Lai J; Wang H; Pan Z; Su F
    Aging (Albany NY); 2019 Jan; 11(2):649-662. PubMed ID: 30696800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients.
    Ge X; Lei S; Wang P; Wang W; Wang W
    Sci Rep; 2024 Feb; 14(1):3500. PubMed ID: 38347041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
    Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
    Front Oncol; 2020; 10():558596. PubMed ID: 33178587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer.
    Zhang P; Yang J; Zhong X; Selistre-de-Araujo HS; Boussios S; Ma Y; Fang H
    Transl Cancer Res; 2024 Mar; 13(3):1554-1566. PubMed ID: 38617520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
    Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
    Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
    Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
    Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.